
    
      This is a prospective longitudinal observational study of patients starting Migalastat as
      part of routine care. Participants will be recruited from outpatient clinics and have a
      number of investigations before starting therapy and after twelve months of therapy.

      Investigations will include a detailed assessment of symptoms and clinical features, blood
      tests, echocardiography, detailed cardiac MRI scans, heart rhythm monitoring and exercise
      capacity assessment.

      Parameters will be assessed at baseline and at twelve months.
    
  